PhotoCamber Pharmaceuticals is recalling Valsartan tablets, USP, in 40-mg, 80-mg, 160-mg and 320-mg doses.

Trace Amounts of N-Nitrosodimethylamine impurity were found in an active pharmaceutical ingredient (API).

NDMA is classified as a probable human carcinogen (a substance that could cause cancer).

The company has not received any reports of adverse events to date related to this recall.

Valsartan, which was distributed nationwide by Qualanex LLC, is a prescription medication used to treat high blood pressure and congestive heart failure, and is packaged in 30-ct & 90-ct bottles

The following lot numbers and expiration dates are being recalled:.

Product DescriptionNDC NumberBatchesExp. Date
Valsartan Tablets USP, 40mg31722-745-30All lots07/2018 - 06/2020
Valsartan Tablets USP, 80mg31722-746-90All lots07/2018 - 06/2020
Valsartan Tablets USP, 160mg31722-747-90All lots07/2018 - 06/2020
Valsartan Tablets USP, 320mg31722-748-90All lots07/2018 - 06/2020

What to do

Consumers should contact their doctor for further guidance and potential change of treatment before they stop taking this product.

Consumers with questions regarding this recall may contact Qualanex at (800) 505-9291 Monday to Friday between 9am – 5pm (CT) or by email at recall@qualanex.com.


Share your Comments